Furthermore, treatment with the pan-hydroxylase inhibitor DMOG suppressed cell proliferation and increased cell death across multiple prostate cancer cell lines (Figure 6C–F), recapitulating the phenotypes observed with PHD1 and PHD3 knockdown. Here, EGLN2 is linked to Familial prostate cancer.